Additionally, the high infiltration of these cells has been associated with more advanced stages, HER2+ status, and high rates of lymph node metastasis, attributed to the secretion of IL-17, which promotes the proliferation of cancer cells, thus contributing to breast tumor progression [136,149]. The gene discussed is ERBB2; the disease is cancer.